Iacovelli, Roberto, et al. “Clinical Outcomes in Patients With Metastatic Renal Cell Carcinoma Receiving Everolimus or Temsirolimus After Sunitinib”. Canadian Urological Association Journal, vol. 8, no. 3-4, Mar. 2014, pp. e121-5, doi:10.5489/cuaj.1604.